MAYNE PHARMA Aktie

 

These shares are having a good time on hump day. But why? The post Why Coronado, DroneShield, Lovisa, and Mayne Pharma shares are racing higher today appeared first on The Motley Fool Australia....

These shares are having a strong finish to the week. But why? The post Why ARB, Block, Mayne Pharma, and Paladin Energy shares are charging higher today appeared first on The Motley Fool Australia....

Mayne Pharma Group (ASX:MYX) has been taking a beating in the markets…...

These shares are having a tough session on Thursday. But why? The post Why Dexus, Mayne Pharma, Nufarm, and Treasury Wine shares are falling today appeared first on The Motley Fool Australia....

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN MAYNE PHARMA GROUP LTD. HG6 AU000000MYX0 AB/FROM ONWARDS 21.05.2025...

Welcome to the halfway point of a busy Wednesday, with a lot…...

These shares are having a tough time on hump day. But why? The post Why James Hardie, Mayne Pharma, Nufarm, and Resimac shares are falling today appeared first on The Motley Fool Australia....

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL MAYNE PHARMA GROUP LTD. HG6 AU000000MYX0 BAW/UFN...

Instrument ID [1887] (HG6 - AU000000MYX0) suspended...

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Mayne Pharma (ASX: MYX) has received a takeover offer at a price of $7.40 per share from US-based pharmaceutical company Cosette Pharma, valuing the company at $672 million. Cosette has a portfolio of products in women's health and dermatology and a long history of manufacturing complex dosage forms including topical creams, ointments, oral liquids/solutions and […] The post Mayne Pharma board backs $672 million takeover bid from Cosette Pharma appeared first on Small Caps....

These shares are ending the week with a bang. Here's why they are jumping. The post Why Domain, Mayne Pharma, QBE, and Telix shares are jumping today appeared first on The Motley Fool Australia....

-- Acquisition Propels Cosette Into One Of The Leading Companies In Women's Health and Dermatology in the U.S. -- -- Highly Complementary Business Strengthens Cosette's Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach -- -- Utilizing Mayne Pharma's Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access -- BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma's Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction. The transaction is expected to close in the second quarter of 2025. “This ...

Mayne Pharma (ASX: MYX) has reported a forecast revenue of between $210 million and $215m for the first half of the 2025 financial year, reflecting growth of approximately 14% on the previous corresponding period (pcp). The company is also expecting to report underlying EBITDA of between $30m and $32m, representing an increase of almost 300% […] The post Mayne Pharma forecasts up to $215m revenue for 1H25 as growth momentum continues appeared first on Small Caps....

These shares are starting the week on a positive note. But why? The post Why Ansell, GQG, Mayne Pharma, and Star shares are charging higher today appeared first on The Motley Fool Australia....

The ASX200 has been down 0.16% at 8,015 points. The market was…...

These shares are ending the week strongly. But why? The post Why Bank of Queensland, Fisher & Paykel, Mayne Pharma, and Medibank shares are rising appeared first on The Motley Fool Australia....

The reporting season continues, with several companies in the food, pharma and…...

Australia's Mayne Pharma hits 10-week high as FY loss narrows...